Exploratory Pharmacokinetic and Pharmacodynamic Study of Oral F/TAF for the Prevention of HIV Acquisition
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 30 Nov 2017
At a glance
- Drugs Emtricitabine/tenofovir alafenamide (Primary)
- Indications HIV infections
- Focus Pharmacokinetics
- 24 Nov 2017 Planned primary completion date changed from 1 Oct 2017 to 1 Nov 2017.
- 24 Nov 2017 Status changed from recruiting to active, no longer recruiting.
- 10 Jun 2017 Biomarkers information updated